Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-06-13

Clinical Trial Update: Parkinsonian Brain Repair Using Human Stem Cells [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating brain repair using human stem cells for idiopathic Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Human stem cell therapy

Snippet

Sponsor: Celavie Bioscences, LLC | Conditions: Idiopathic Parkinson Disease | Phase 1 | Status: UNKNOWN